NCT03955692

Brief Summary

The purpose of this study is to investigate the effectiveness of five sessions of cathodal tDCS over the left DLPFC on inhibitory control/response inhibition in children and adolescents with ADHD. Investigators hypothesize that multiple sessions of cathodal tDCS will induce a greater and long-term effect on inhibitory response in children and adolescents with ADHD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 16, 2017

Completed
29 days until next milestone

Study Start

First participant enrolled

December 15, 2017

Completed
1.4 years until next milestone

First Posted

Study publicly available on registry

May 20, 2019

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2019

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

August 6, 2020

Status Verified

August 1, 2020

Enrollment Period

1.5 years

First QC Date

November 16, 2017

Last Update Submit

August 4, 2020

Conditions

Outcome Measures

Primary Outcomes (6)

  • Change of accuracy rate

    Accuracy rate from go/no-go tasks

    Change from baseline to Day 0 after tDCS (T1)

  • Change of accuracy rate

    Accuracy rate from go/no-go tasks

    Change from Day 0 to 1 week after tDCS (T2)

  • Change of accuracy rate

    Accuracy rate from go/no-go tasks

    Change form 1 week to 1 month after tDCS (T3)

  • Change in the amplitude of ERP recording

    The amplitude of the ERP components (N2 and P3) in average will be use as outcome measures to evaluate response inhibition.

    Change from baseline to Day 0 after tDCS (T1)

  • Change in the amplitude of ERP recording

    The amplitude of the ERP components (N2 and P3) in average will be use as outcome measures to evaluate response inhibition.

    Change from Day 0 to 1 week after tDCS (T2)

  • Change in the amplitude of ERP recording

    The amplitude of the ERP components (N2 and P3) in average will be use as outcome measures to evaluate response inhibition.

    Change form 1 week to 1 month after tDCS (T3)

Study Arms (2)

Active tDCS

ACTIVE COMPARATOR

Cathodal tDCS will be applied over the left DLPFC (F3) according to the 10-20 EEG electrode systems and the anode will be placed over the right supraorbital (Fp2), using rectangular saline-soaked sponge pads 35 cm2. The current intensity of 1.5 mA will be used for 15 mins for a session.

Device: tDCS

Sham tDCS

SHAM COMPARATOR

Cathodal tDCS will be applied over the left DLPFC (F3) according to the 10-20 EEG electrode systems and the anode will be placed over the right supraorbital (Fp2), using rectangular saline-soaked sponge pads 35 cm2. The current intensity of 1.5 mA will flow continuously only 120 seconds. The electrode will be attached until the end of stimulation even the current flows only at the beginning.

Device: tDCS

Interventions

tDCSDEVICE

Five sessions (active/sham) will be held on five consecutive days. The parameter of electrode size, current strength and current duration were previously tested for safety in children

Active tDCSSham tDCS

Eligibility Criteria

Age7 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children and adolescents aged 7 to 16 years with suspected ADHD according to the Diagnostic and Statistical Manual of Mental Disorders-5th edition (DSM-5TM). Diagnostic confirmation will be performed by pediatric neurologist or psychologist.
  • Right-handed
  • Free of any neurological antecedent, unstable medical conditions such as epilepsy; although tDCS is believed to induce very less or no risk of seizure and epileptic seizure have never been reported in tDCS study even in a study with active epilepsy.

You may not qualify if:

  • Be unable to understand the instruction
  • No clear neurological antecedent history
  • Presence of intracranial metal implantation, cochlea implant, or cardiac pacemaker
  • Motor or perceptual handicap that would prevent using the computer program
  • For patients who under medication, poor-adjusted to their medication, type and dosage of medication is changed less than 4 weeks prior to the start
  • Subjects are participating in the other protocol or receiving alternative treatment such transcranial magnetic stimulation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty ofPhysical Therapy, Mahidol University

Salaya, Nakonpathom, 73170, Thailand

Location

Related Publications (1)

  • Klomjai W, Siripornpanich V, Aneksan B, Vimolratana O, Permpoonputtana K, Tretriluxana J, Thichanpiang P. Effects of cathodal transcranial direct current stimulation on inhibitory and attention control in children and adolescents with attention-deficit hyperactivity disorder: A pilot randomized sham-controlled crossover study. J Psychiatr Res. 2022 Jun;150:130-141. doi: 10.1016/j.jpsychires.2022.02.032. Epub 2022 Mar 2.

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Wanalee Klomjai, PhD

    Mahidol University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 16, 2017

First Posted

May 20, 2019

Study Start

December 15, 2017

Primary Completion

July 1, 2019

Study Completion

December 1, 2019

Last Updated

August 6, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations